Olovnikov AM (1973). "A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon". J. Theor. Biol.41 (1): 181–90. PMID4754905. doi:10.1016/0022-5193(73)90198-7.
Greider CW, Blackburn EH (1985). "Identification of a specific telomere terminal transferase activity in Tetrahymena extracts". Cell43 (2 Pt 1): 405–13. PMID3907856. doi:10.1016/0092-8674(85)90170-9.
Cohen S, Graham M, Lovrecz G, Bache N, Robinson P, Reddel R (2007). "Protein composition of catalytically active human telomerase from immortal cells". Science315 (5820): 1850–3. PMID17395830. doi:10.1126/science.1138596.
Gillis AJ, Schuller AP, Skordalakes E (2008). "Structure of the Tribolium castaneum telomerase catalytic subunit TERT". Nature455 (7213): 633–7. PMID18758444. doi:10.1038/nature07283.
Blasco MA (2005). "Telomeres and human disease: ageing, cancer and beyond". Nat. Rev. Genet.6 (8): 611–22. PMID16136653. doi:10.1038/nrg1656.
de Magalhães JP, Toussaint O (2004). "Telomeres and telomerase: a modern fountain of youth?". Rejuvenation Res7 (2): 126–33. PMID15312299. doi:10.1089/1549168041553044.
Tomás-Loba A, Flores I, Fernández-Marcos PJ, Cayuela ML, Maraver A, Tejera A, Borrás C, Matheu A, Klatt P, Flores JM, Viña J, Serrano M, Blasco MA (2008). "Telomerase reverse transcriptase delays aging in cancer-resistant mice". Cell135 (4): 609–22. PMID19013273. doi:10.1016/j.cell.2008.09.034.
Blackburn EH (2005). "Telomeres and telomerase: their mechanisms of action and the effects of altering their functions". FEBS Lett.579 (4): 859–62. PMID15680963. doi:10.1016/j.febslet.2004.11.036.
Yamaguchi H (2007). "Mutations of telomerase complex genes linked to bone marrow failures". J Nippon Med Sch74 (3): 202–9. PMID17625368. doi:10.1272/jnms.74.202.
Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ, Poustka A, Dokal I (1998). "X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions". Nat. Genet.19 (1): 32–8. PMID9590285. doi:10.1038/ng0598-32.
Vulliamy TJ, Walne A, Baskaradas A, Mason PJ, Marrone A, Dokal I (2005). "Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure". Blood Cells Mol. Dis.34 (3): 257–63. PMID15885610. doi:10.1016/j.bcmd.2004.12.008.
Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, Dokal I (2001). "The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita". Nature413 (6854): 432–5. PMID11574891. doi:10.1038/35096585.
Marrone A, Walne A, Dokal I (2005). "Dyskeratosis congenita: telomerase, telomeres and anticipation". Curr. Opin. Genet. Dev.15 (3): 249–57. PMID15917199. doi:10.1016/j.gde.2005.04.004.
Olovnikov AM (1973). "A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon". J. Theor. Biol.41 (1): 181–90. PMID4754905. doi:10.1016/0022-5193(73)90198-7.
Greider CW, Blackburn EH (1985). "Identification of a specific telomere terminal transferase activity in Tetrahymena extracts". Cell43 (2 Pt 1): 405–13. PMID3907856. doi:10.1016/0092-8674(85)90170-9.
Cohen S, Graham M, Lovrecz G, Bache N, Robinson P, Reddel R (2007). "Protein composition of catalytically active human telomerase from immortal cells". Science315 (5820): 1850–3. PMID17395830. doi:10.1126/science.1138596.
Blasco MA (2005). "Telomeres and human disease: ageing, cancer and beyond". Nat. Rev. Genet.6 (8): 611–22. PMID16136653. doi:10.1038/nrg1656.
de Magalhães JP, Toussaint O (2004). "Telomeres and telomerase: a modern fountain of youth?". Rejuvenation Res7 (2): 126–33. PMID15312299. doi:10.1089/1549168041553044.
Tomás-Loba A, Flores I, Fernández-Marcos PJ, Cayuela ML, Maraver A, Tejera A, Borrás C, Matheu A, Klatt P, Flores JM, Viña J, Serrano M, Blasco MA (2008). "Telomerase reverse transcriptase delays aging in cancer-resistant mice". Cell135 (4): 609–22. PMID19013273. doi:10.1016/j.cell.2008.09.034.
Blackburn EH (2005). "Telomeres and telomerase: their mechanisms of action and the effects of altering their functions". FEBS Lett.579 (4): 859–62. PMID15680963. doi:10.1016/j.febslet.2004.11.036.
Yamaguchi H (2007). "Mutations of telomerase complex genes linked to bone marrow failures". J Nippon Med Sch74 (3): 202–9. PMID17625368. doi:10.1272/jnms.74.202.
Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ, Poustka A, Dokal I (1998). "X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions". Nat. Genet.19 (1): 32–8. PMID9590285. doi:10.1038/ng0598-32.
Vulliamy TJ, Walne A, Baskaradas A, Mason PJ, Marrone A, Dokal I (2005). "Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure". Blood Cells Mol. Dis.34 (3): 257–63. PMID15885610. doi:10.1016/j.bcmd.2004.12.008.
Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, Dokal I (2001). "The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita". Nature413 (6854): 432–5. PMID11574891. doi:10.1038/35096585.
Marrone A, Walne A, Dokal I (2005). "Dyskeratosis congenita: telomerase, telomeres and anticipation". Curr. Opin. Genet. Dev.15 (3): 249–57. PMID15917199. doi:10.1016/j.gde.2005.04.004.